BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22085360)

  • 1. Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node.
    Tvedskov TF; Bartels A; Jensen MB; Paaschburg B; Kroman N; Balslev E; Brünner N
    APMIS; 2011 Dec; 119(12):844-52. PubMed ID: 22085360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases.
    Leidenius MH; Vironen JH; Riihelä MS; Krogerus LA; Toivonen TS; von Smitten KA; Heikkilä PS
    Eur J Surg Oncol; 2005 Feb; 31(1):13-8. PubMed ID: 15642420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis.
    Houvenaeghel G; Nos C; Giard S; Mignotte H; Esterni B; Jacquemier J; Buttarelli M; Classe JM; Cohen M; Rouanet P; Penault Llorca F; Bonnier P; Marchal F; Garbay JR; Fraisse J; Martel P; Fondrinier E; Tunon de Lara C; Rodier JF
    Eur J Surg Oncol; 2009 Jul; 35(7):690-5. PubMed ID: 19046847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node.
    Tvedskov TF; Jensen MB; Lisse IM; Ejlertsen B; Balslev E; Kroman N
    Int J Cancer; 2012 Nov; 131(10):2367-75. PubMed ID: 22344558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node.
    Farshid G; Pradhan M; Kollias J; Gill PG
    Breast; 2004 Dec; 13(6):494-501. PubMed ID: 15563857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node.
    Schrenk P; Konstantiniuk P; Wölfl S; Bogner S; Haid A; Nemes C; Jagoutz-Herzlinger M; Redtenbacher S
    Br J Surg; 2005 Jun; 92(6):707-13. PubMed ID: 15810047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models.
    Houvenaeghel G; Bannier M; Nos C; Giard S; Mignotte H; Jacquemier J; Martino M; Esterni B; Belichard C; Classe JM; Tunon de Lara C; Cohen M; Payan R; Blanchot J; Rouanet P; Penault-Llorca F; Bonnier P; Fournet S; Agostini A; Marchal F; Garbay JR
    Breast; 2012 Apr; 21(2):204-9. PubMed ID: 22014859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of nonsentinel lymph node metastasis in sentinel node-positive breast carcinoma.
    Kapur U; Rubinas T; Ghai R; Sinacore J; Yao K; Rajan PB
    Ann Diagn Pathol; 2007 Feb; 11(1):10-2. PubMed ID: 17240301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options.
    Gentilini O; Masullo M; Rotmensz N; Peccatori F; Mazzarol G; Smeets A; Simsek S; De Dosso S; Veronesi P; Intra M; Zurrida S; Viale G; Goldhirsch A; Veronesi U
    Eur J Surg Oncol; 2005 Apr; 31(3):232-6. PubMed ID: 15780556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
    Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
    Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust and validated models to predict high risk of non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node.
    Tvedskov TF; Jensen MB; Balslev E; Kroman N
    Acta Oncol; 2014 Feb; 53(2):209-15. PubMed ID: 23772767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The positive non-sentinel status is not the main decisional factor for chemotherapy assignment in breast cancer with micrometastatic disease in the sentinel lymph node.
    Mazouni C; Reitsamer R; Rimareix F; Stranzl H; Uzan C; Garbay JR; Delaloge S; Peintinger F
    J Surg Oncol; 2012 Nov; 106(6):703-7. PubMed ID: 22674094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
    Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of sentinel node involvement in gastric cancer.
    Morita D; Tsuda H; Ichikura T; Kimura M; Aida S; Kosuda S; Inazawa J; Mochizuki H; Matsubara O
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1046-52. PubMed ID: 17632042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary recurrence is low in patients with breast cancer who do not undergo completion axillary lymph node dissection for micrometastases in sentinel lymph nodes.
    Rayhanabad J; Yegiyants S; Putchakayala K; Haig P; Romero L; Difronzo LA
    Am Surg; 2010 Oct; 76(10):1088-91. PubMed ID: 21105616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.